The Internal Prospective Validation of the Cancer Admission Score (CAS) Prediction Model
Recruiting now
Conditions studied: Oncology
In brief
The goal of this single center prospective observational study is to determine the agreement between the cancer admission score (CAS) predicted disposition and the actual disposition in patients with an active cancer diagnosis visiting the emergency department (ED). The main question it aims to answer are: Is the performance of the CAS good enough to play a potential role in the ED care process. For each participant the CAS will be calculated and compared to the actual outcome.
Key facts
- Study ID
- NCT06558487
- Run by
- Erasmus Medical Center
- People needed
- 200
- Starts
- 2024-12-02
- Expected to finish
- 2025-12-31
- Last updated by the study team
- 2025-08-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with solid or hematological malignancies and receiving systemic therapy or having received systemic therapy within the last 3 months.
- Presented at or admitted from the emergency department for the oncology, hematology neuro- or lung-oncology clinical unit.
You may not qualify if…
- <18 years old
- Only received a surgical intervention as cancer treatment
- Admitted to the ED for the surgical department
Where it is running
- Erasmus University Medical Center — Rotterdam, South Holland, Netherlands (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.